Related Experiment Video
Updated: May 14, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Hyperhomocysteinaemia and chronic venous ulcers
Stefano de Franciscis1, Giovambattista De Sarro, Paola Longo
1Department of Medical and Surgical Science, School of Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy; Interuniversity Center of Phlebolymphology, International Research and Educational Program in Clinical and Experimental Biotechnology, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Insights
Hyperhomocysteinemia (HHcy) is common in chronic venous ulcers (CVU). Folic acid therapy improved healing rates in patients with HHcy, suggesting a link between homocysteine levels and venous ulcer recovery.
Area of Science:
- Vascular Medicine
- Dermatology
- Wound Healing Research
Background:
- Chronic venous ulceration (CVU) is a significant complication of chronic venous disease affecting lower extremities.
- Previous research suggests a potential link between thrombophilic factors, like hyperhomocysteinemia (HHcy), and the development of chronic venous ulcers.
Purpose of the Study:
- To determine the prevalence of HHcy in patients diagnosed with venous leg ulcers.
- To investigate the impact of folic acid therapy on the healing of chronic venous ulcers in patients with HHcy.
Main Methods:
- Eighty-seven patients with venous leg ulcers were enrolled.
- All patients received standard care (compression therapy ± surgery).
- Patients with HHcy received folic acid (1.2 mg/day for 12 months), while controls did not. Wound healing was assessed using computerized planimetry.
Main Results:
- The prevalence of HHcy among patients with chronic venous ulcers was found to be 62.06%.
- A statistically significant higher healing rate (P < 0.05) was observed in the folic acid treatment group (78.75%) compared to the control group (63.33%).
Conclusions:
- A significant association exists between hyperhomocysteinemia and chronic venous ulceration.
- Folic acid therapy appears to accelerate wound healing in patients with HHcy and CVU, though underlying mechanisms require further investigation.
Abstract:
Chronic venous ulceration (CVU) is the major cause of chronic wounds of lower extremities, and is a part of the complex of chronic venous disease. Previous studies have hypothesised that several thrombophilic factors, such as hyperhomocysteinaemia (HHcy), may be associated with chronic venous ulcers. In this study, we evaluated the prevalence of HHcy in patients with venous leg ulcers and the effect of folic acid therapy on wound healing. Eighty-seven patients with venous leg ulcers were enrolled in this study to calculate the prevalence of HHcy in this population. All patients underwent basic treatment for venous ulcer (compression therapy ± surgical procedures). Patients with HHcy (group A) received basic treatment and administered folic acid (1·2 mg/day for 12 months) and patients without HHcy (group B) received only basic treatment. Healing was assessed by means of computerised planimetry analysis. The prevalence of HHcy among patients with chronic venous ulcer enrolled in this study was 62·06%. Healing rate was significantly higher (P < 0·05) in group A patients (78·75%) compared with group B patients (63·33%). This study suggests a close association, statistically significant, between HHcy and CVU. Homocysteine-lowering therapy with folic acid seems to expedite wound healing. Despite these aspects, the exact molecular mechanisms between homocysteine and CVU have not been clearly defined and further studies are needed.
Related Concept Videos
Venous Thrombosis I: Introduction
Portal Hypertension
Esophageal Varices-I: Introduction
Venous Thrombosis IV: Nursing Management
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction

